On the public citation graph
Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity
0 signed · 123 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.282.14.1344openalex-snapshot
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis A Randomized Controlled Trial
inferredcites →https://doi.org/10.1001/jama.285.14.1850openalex-snapshot
Use of Statins and Risk of Fractures
inferredcites →https://doi.org/10.1001/jama.288.3.321openalex-snapshot
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
inferredcites →https://doi.org/10.1002/1099-1557(200009/10)9:5<359::aid-pds507>3.0.co;2-eopenalex-snapshot
The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results
inferredcites →https://doi.org/10.1002/jbmr.1998openalex-snapshot
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
inferredcites →https://doi.org/10.1002/jbmr.2565openalex-snapshot
Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996–2012: An Ecological Analysis
inferredcites →https://doi.org/10.1002/pds.3703openalex-snapshot
Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy
inferredcites →https://doi.org/10.1007/978-3-030-78128-6_7openalex-snapshot
The Osteoporosis Treatment Gap
inferredcites →https://doi.org/10.1007/bf01623276openalex-snapshot
Consequences of a hip fracture: A prospective study over 1 year
inferredcites →https://doi.org/10.1007/s00198-004-1675-5openalex-snapshot
Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review
inferredcites →https://doi.org/10.1007/s00198-006-0172-4openalex-snapshot
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
inferredcites →https://doi.org/10.1007/s00198-008-0587-1openalex-snapshot
Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study
inferredcites →https://doi.org/10.1007/s00198-008-0831-8openalex-snapshot
Factors associated with diagnosis and treatment of osteoporosis in older adults
inferredcites →https://doi.org/10.1007/s00198-014-2747-9openalex-snapshot
Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data
inferredcites →https://doi.org/10.1007/s00198-015-3098-xopenalex-snapshot
Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010
inferredcites →https://doi.org/10.1007/s00198-015-3249-0openalex-snapshot
Disparities in osteoporosis treatments
inferredcites →https://doi.org/10.1007/s00198-016-3650-3openalex-snapshot
Secular trends in fracture incidence in the UK between 1990 and 2012
inferredcites →https://doi.org/10.1007/s00228-007-0320-6openalex-snapshot
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005
inferredcites →https://doi.org/10.1007/s00228-009-0746-0openalex-snapshot
Prescription of anti-osteoporosis drugs during 2004–2007—a nationwide register study in Norway
inferredcites →https://doi.org/10.1007/s11657-011-0060-1openalex-snapshot
Osteoporosis: burden, health care provision and opportunities in the EU
inferredcites →https://doi.org/10.1007/s11657-013-0136-1openalex-snapshot
Osteoporosis in the European Union: medical management, epidemiology and economic burden
inferredcites →https://doi.org/10.1007/s11657-015-0233-4openalex-snapshot
Comorbidities, bone-sparing agent prescription history and their determinants among postmenopausal women in UK primary care settings: a retrospective database study
inferredcites →https://doi.org/10.1016/j.bone.2004.03.024openalex-snapshot
A meta-analysis of previous fracture and subsequent fracture risk
inferredcites →https://doi.org/10.1016/j.bone.2013.09.008openalex-snapshot
Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002–2012
inferredcites →https://doi.org/10.1016/j.bone.2016.03.006openalex-snapshot
Epidemiology of fractures in the United Kingdom 1988–2012: Variation with age, sex, geography, ethnicity and socioeconomic status
inferredcites →https://doi.org/10.1016/j.maturitas.2008.11.022openalex-snapshot
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
inferredcites →https://doi.org/10.1016/j.semarthrit.2005.11.001openalex-snapshot
Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon
inferredcites →https://doi.org/10.1016/s0140-6736(96)07088-2openalex-snapshot
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
inferredcites →https://doi.org/10.1017/s1463423612000114openalex-snapshot
Osteoporosis prescribing trends in primary care: a population-based retrospective cohort study
inferredcites →https://doi.org/10.1093/ije/dyv098openalex-snapshot
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
inferredcites →https://doi.org/10.1093/pubmed/fdt116openalex-snapshot
Completeness and usability of ethnicity data in UK-based primary care and hospital databases
inferredcites →https://doi.org/10.1111/j.1365-2125.2009.03537.xopenalex-snapshot
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
inferredcites →https://doi.org/10.1111/j.1445-5994.2007.01496.xopenalex-snapshot
First Fracture Project: addressing the osteoporosis care gap
inferredcites →https://doi.org/10.1136/bmj.300.6732.1092openalex-snapshot
The Read clinical classification.
inferredcites →https://doi.org/10.1177/2042098611435911openalex-snapshot
Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource
inferredcites →https://doi.org/10.1359/jbmr.041231openalex-snapshot
Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the Hip Fracture Projections Wrong?
inferredcites →https://doi.org/10.2106/jbjs.l.01781openalex-snapshot
Declining Rates of Osteoporosis Management Following Fragility Fractures in the U.S., 2000 Through 2009
inferredcites →https://doi.org/10.3111/200104051062openalex-snapshot
The cost of osteoporotic fractures in the UK: projections for 2000–2020
inferredcites →https://doi.org/10.3399/bjgp10x483562openalex-snapshot
Validity of diagnostic coding within the General Practice Research Database: a systematic review
inferredcites →https://doi.org/10.3399/bjgp11x583092openalex-snapshot
Validity of diagnoses in the General Practice Research Database
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4685954openalex-extracted
Trends in Osteoporosis Medication Use in Japan: An Analysis of the National Database Sampling Data from 2011 to 2020
inferred← citeshttps://doi.org/10.1002/14651858.cd001155.pub3openalex-snapshot
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
inferred← citeshttps://doi.org/10.1002/14651858.cd004523.pub4openalex-snapshot
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
inferred← citeshttps://doi.org/10.1002/9781119413431.ch13openalex-snapshot
Electronic Health Record Databases
inferred← citeshttps://doi.org/10.1002/jbmr.3679openalex-snapshot
Effect of Alendronic Acid on Fracture Healing: A Multicenter Randomized Placebo-Controlled Trial
inferred← citeshttps://doi.org/10.1002/jbmr.4028openalex-snapshot
Trends and Geographical Variability in Osteoporosis Treatment After Hip Fracture: A Multilevel Analysis of 30,965 Patients in the Region of Valencia, Spain
inferred← citeshttps://doi.org/10.1002/jbmr.4821openalex-snapshot
Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality
inferred← citeshttps://doi.org/10.1007/978-3-030-78128-6_2openalex-snapshot
How to Identify Individuals Requiring Anti-osteoporosis Therapy: Imaging in Bone Health
inferred← citeshttps://doi.org/10.1007/978-3-030-78128-6_7openalex-snapshot
The Osteoporosis Treatment Gap
inferred← citeshttps://doi.org/10.1007/s00198-017-4009-0openalex-snapshot
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
inferred← citeshttps://doi.org/10.1007/s00198-017-4161-6openalex-snapshot
Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
inferred← citeshttps://doi.org/10.1007/s00198-019-05061-zopenalex-snapshot
Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes
inferred← citeshttps://doi.org/10.1007/s00198-019-05064-wopenalex-snapshot
Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom
inferred← citeshttps://doi.org/10.1007/s00198-020-05479-wopenalex-snapshot
Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan
inferred← citeshttps://doi.org/10.1007/s00198-021-06058-3openalex-snapshot
Sex differences in recovery of quality of life 12 months post-fracture in community-dwelling older adults: analyses of the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS)
inferred← citeshttps://doi.org/10.1007/s11657-019-0661-7openalex-snapshot
Osteoporosis medication use among Australian women over two decades
inferred← citeshttps://doi.org/10.1007/s11657-020-00798-1openalex-snapshot
Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010–2016 in Fujian, China
inferred← citeshttps://doi.org/10.1007/s11845-021-02571-wopenalex-snapshot
Assessment of previous fracture and anti-osteoporotic medication prescription in hip fracture patients
inferred← citeshttps://doi.org/10.1007/s11914-020-00566-7openalex-snapshot
General and Specific Considerations as to why Osteoporosis-Related Care Is Often Suboptimal
inferred← citeshttps://doi.org/10.1007/s40618-019-01041-6openalex-snapshot
State of the art in osteoporosis risk assessment and treatment
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.99202-xopenalex-snapshot
Osteoporosis: Treatment Gaps and Health Economics
inferred← citeshttps://doi.org/10.1016/b978-0-443-13825-6.00054-6openalex-snapshot
Osteoporosis: Treatment gaps and health economics
inferred← citeshttps://doi.org/10.1016/j.afos.2020.11.007openalex-snapshot
The secular trends in the use of medications for osteoporosis in South Korea using Intercontinental Medical Statistics Health Sales Audit 2006–2018
inferred← citeshttps://doi.org/10.1016/j.afos.2021.09.001openalex-snapshot
Prevalence of osteoporosis in elderly women in Hong Kong
inferred← citeshttps://doi.org/10.1016/j.berh.2022.101754openalex-snapshot
Osteoporosis in 2022: Care gaps to screening and personalised medicine
inferred← citeshttps://doi.org/10.1016/j.bone.2017.01.024openalex-snapshot
The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide
inferred← citeshttps://doi.org/10.1016/j.bone.2017.08.031openalex-snapshot
Secular trends of use of anti-osteoporotic treatments in Spain: A population-based cohort study including over 1.5 million people and more than 12 years of follow-up
inferred← citeshttps://doi.org/10.1016/j.bone.2018.12.016openalex-snapshot
Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture prevention
inferred← citeshttps://doi.org/10.1016/j.bone.2019.04.003openalex-snapshot
Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women
inferred← citeshttps://doi.org/10.1016/j.bone.2019.115125openalex-snapshot
Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: A practice-level prescribing data analysis in 2013-2018
inferred← citeshttps://doi.org/10.1016/j.bone.2020.115752openalex-snapshot
Trends in hip and distal femoral fracture rates in Italy from 2007 to 2017
inferred← citeshttps://doi.org/10.1016/j.bone.2021.116255openalex-snapshot
Trends in postmenopausal osteoporosis treatment in France during the period 2007–2016: A nationwide claims database analysis
inferred← citeshttps://doi.org/10.1016/j.bone.2021.116297openalex-snapshot
Bisphosphonates and the risk of atypical femur fractures
inferred← citeshttps://doi.org/10.1016/j.cyto.2024.156729openalex-snapshot
Causal relationship between circulating levels of cytokines and bone mineral density: A mendelian randomization study
inferred← citeshttps://doi.org/10.1016/j.ijotn.2017.04.004openalex-snapshot
Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide
inferred← citeshttps://doi.org/10.1016/j.jfma.2023.05.012openalex-snapshot
Constraining in reimbursement criteria and the adherence to anti-osteoporosis medications (AOMs) in Taiwan: Urbanization makes the difference
inferred← citeshttps://doi.org/10.1016/j.jocd.2021.09.001openalex-snapshot
Relationship Between Muscle Strength, Body Composition and Bone Mineral Density in Adolescents
inferred← citeshttps://doi.org/10.1016/j.jor.2025.12.069openalex-snapshot
A decade of progress and paradigm shifts in osteoporosis therapeutics: A bibliometric analysis
inferred← citeshttps://doi.org/10.1016/j.puhe.2018.05.002openalex-snapshot
Inequalities in hip fracture incidence are greatest in the North of England: regional analysis of the effects of social deprivation on hip fracture incidence across England
inferred← citeshttps://doi.org/10.1016/j.radi.2023.08.011openalex-snapshot
Understanding patient views and acceptability of predictive software in osteoporosis identification
inferred← citeshttps://doi.org/10.1016/j.rhum.2019.01.005openalex-snapshot
Consommation des traitements antiostéoporotiques et incidence des fractures ostéoporotiques en France entre 2014 et 2016 : une prise en charge médicamenteuse insuffisante
inferred← citeshttps://doi.org/10.1016/j.semcancer.2019.12.001openalex-snapshot
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment
inferred← citeshttps://doi.org/10.1016/j.spinee.2017.04.014openalex-snapshot
The computed tomography-based fractal analysis of trabecular bone structure may help in detecting decreased quality of bone before urgent spinal procedures
inferred← citeshttps://doi.org/10.1016/j.spinee.2021.12.007openalex-snapshot
Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019
inferred← citeshttps://doi.org/10.1038/s41413-023-00306-4openalex-snapshot
Insights and implications of sexual dimorphism in osteoporosis
inferred← citeshttps://doi.org/10.1038/s41533-020-0162-6openalex-snapshot
A retrospective database study of oral corticosteroid and bisphosphonate prescribing patterns in England
inferred← citeshttps://doi.org/10.1038/s41574-019-0220-8openalex-snapshot
Fracture prediction, imaging and screening in osteoporosis
inferred← citeshttps://doi.org/10.1097/bor.0000000000000596openalex-snapshot
Changing rates in fracture trends are temporally associated with declining testing and treatment: reality or ecologic fallacy?
inferred← citeshttps://doi.org/10.1097/corr.0000000000002465openalex-snapshot
What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019
inferred← citeshttps://doi.org/10.1097/gme.0000000000002063openalex-snapshot
Trends in osteoporosis medication use in US postmenopausal women: analysis of the National Health and Nutrition Examination Survey 1999-2000 through 2017-2018
inferred← citeshttps://doi.org/10.1101/2022.09.30.22280548openalex-snapshot
Characterising complex health needs and the use of preventative therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data
inferred← citeshttps://doi.org/10.11138/ccmbm/2017.14.1.048openalex-snapshot
The use of cholecalciferol in patients with hip fracture
inferred← citeshttps://doi.org/10.1136/annrheumdis-2018-eular.4198openalex-snapshot
AB0983 Hyaluronan derivative hymovis® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from mokha study
inferred← citeshttps://doi.org/10.1136/bmjopen-2018-028355openalex-snapshot
Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005–2015
inferred← citeshttps://doi.org/10.1161/jaha.116.004601openalex-snapshot
Incidence of First Stroke in Pregnant and Nonpregnant Women of Childbearing Age: A Population‐Based Cohort Study From England
inferred← citeshttps://doi.org/10.1177/1759720x17732562openalex-snapshot
Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs
inferred← citeshttps://doi.org/10.1186/s12877-023-03770-zopenalex-snapshot
Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data
inferred← citeshttps://doi.org/10.1186/s12903-024-04206-9openalex-snapshot
Global, regional, and national burden of incidence, prevalence, and years lived with disability for facial fractures from 1990 to 2019: a systematic analysis for the Global Burden of Disease study 2019
inferred← citeshttps://doi.org/10.12968/npre.2016.14.12.582openalex-snapshot
Research roundup: December 2016
inferred← citeshttps://doi.org/10.17925/ee.2017.13.01.19openalex-snapshot
Progress and Problems in Bone and Mineral Disorders
inferred← citeshttps://doi.org/10.20452/pamw.16316openalex-snapshot
Changes in osteoporosis therapy in postmenopausal women from the RAC-OST-POL Study: a 10-year follow-up
inferred← citeshttps://doi.org/10.2147/copd.s264580openalex-snapshot
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study
inferred← citeshttps://doi.org/10.2174/1573397118666220510162127openalex-snapshot
The Importance of Fracture Liaison Services to the Healthcare System: A Review
inferred← citeshttps://doi.org/10.2478/sjph-2026-0022openalex-snapshot
Osteoporosis Treatment Gap — A Systematic Literature Review
inferred← citeshttps://doi.org/10.26481/dis.20220713rvopenalex-snapshot
Epidemiology of clinical fractures, morphometric vertebral fractures and osteoporosis treatment
inferred← citeshttps://doi.org/10.3389/fendo.2020.630875openalex-snapshot
Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis and Bone Research Academy of the Royal Osteoporosis Society on October 5th 2020
inferred← citeshttps://doi.org/10.3389/fendo.2022.870905openalex-snapshot
Global, Regional, and National Burden of Low Bone Mineral Density From 1990 to 2019: Results From the Global Burden of Disease Study 2019
inferred← citeshttps://doi.org/10.3389/fmicb.2026.1768890openalex-snapshot
Combined polysaccharides from Angelica sinensis, Crataegus pinnatifida, Prunus persica, and Carthamus tinctorius attenuate cold exposure-induced bone loss by modulating the gut microbiota and fecal metabolites
inferred← citeshttps://doi.org/10.3389/fphar.2019.00768openalex-snapshot
Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015
inferred← citeshttps://doi.org/10.3389/fpubh.2025.1627867openalex-snapshot
Global epidemiology, burden, and causes of lower extremity and pelvic fractures in the past 32 years
inferred← citeshttps://doi.org/10.3399/bjgp19x705089openalex-snapshot
Antibiotic exposure and ‘response failure’ for subsequent respiratory tract infections: an observational cohort study of UK preschool children in primary care
inferred← citeshttps://doi.org/10.36104/amc.2024.3042openalex-snapshot
Fractura atípica de cadera asociada con uso de bifosfonatos
inferred← citeshttps://doi.org/10.48035/tesis/2454/41089openalex-snapshot
The importance of health technology assessment to ensure an efficient and equitable access to high-cost therapies
inferred← citeshttps://doi.org/10.5114/aoms/209584openalex-snapshot
Global, regional, and national trends in spinal fracture burden from 1990 to 2021 and projections to 2050
inferred← citeshttps://doi.org/10.5603/njo.2023.0018openalex-snapshot
Osteoporosis – a partially recognized challenge for oncology
inferred← citeshttps://doi.org/10.6084/m9.figshare.22604239openalex-snapshot
Additional file 1 of Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data
inferred← citeshttps://doi.org/10.6084/m9.figshare.22604242openalex-snapshot
Additional file 2 of Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data
inferred← citeshttps://doi.org/10.6084/m9.figshare.25583910openalex-snapshot
Additional file 1 of Global, regional, and national burden of incidence, prevalence, and years lived with disability for facial fractures from 1990 to 2019: a systematic analysis for the Global Burden of Disease study 2019
inferred← citeshttps://doi.org/10.6084/m9.figshare.25584022openalex-snapshot
Additional file 2 of Global, regional, and national burden of incidence, prevalence, and years lived with disability for facial fractures from 1990 to 2019: a systematic analysis for the Global Burden of Disease study 2019
inferred← citeshttps://doi.org/10.6084/m9.figshare.26704659openalex-snapshot
Additional file 3 of Global, regional, and national burden of incidence, prevalence, and years lived with disability for facial fractures from 1990 to 2019: a systematic analysis for the Global Burden of Disease study 2019
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.